Alys Pharmaceuticals Email Formats

Biotechnology Research • United States • 1-10 Employees

Alys Pharmaceuticals Email Formats

Alys Pharmaceuticals uses 2 email formats. The most common is {first initial}{last name} (e.g., jdoe@alyspharma.com), used 75% of the time.

Format	Example	Percentage
{first initial}{last name}	jdoe@alyspharma.com	75%
{first name}{last name}	johndoe@alyspharma.com	25%

Key Contacts at Alys Pharmaceuticals

Brian S. Kim

Co-Founder

Thibaud Portal

Founder

Mark Prausnitz

Co-Founder

Yann Dean

Co-Founder & Project Lead

Amissi Sadiki

Founder & Head Of Chemistry, Nira Biosciences, Subsidiary Of Alys Pharmaceuticals

Company overview

Headquarters	United States
Website	alyspharma.com
NAICS	541714
Founded	2024
Employees	1-10
Socials

About Alys Pharmaceuticals

Launched in February 2024, Alys Pharmaceuticals is an innovation leader in immuno-dermatology, co-founded by Medixci and world-leading dermatology and scientific experts. Originating from the aggregation of six asset-centric Medixci compannies, Alys boasts a robust pipeline of innovative programs and platforms targeting multiple dermatological indications. With a vision to transform the treatment paradigm for several dermatology indications of significant prevalence and major unmet medical need, Alys aspires to redefine the landscape of dermatological treatments. Alys combines the assets and platforms of Aldena Therapeutics, Graegis Pharmaceuticals, Granular Therapeutics, Klirna Biotech, Nira Biosciences and Vimela Therapeutics, and has a number of strategic collaborations with leading research institutions.

Employees by Management Level

Total employees: 1-10

Seniority

Employees

Founder/Owner

C-Suite

Entry

Employees by Department

Alys Pharmaceuticals has 6 employees across 4 departments.

Departments

Number of employees

Funding Data

Explore Alys Pharmaceuticals's funding history, including investment rounds, total capital raised, and key backers.

Funding Date	Round	Amount	Link to Article
2024-03-12	3	$100,000,000

Funding Insights

$100,000,000

Total funding amount

$100,000,000

Most recent funding amount

Number of funding rounds

Alys Pharmaceuticals Tech Stack

Discover the technologies and tools that power Alys Pharmaceuticals's digital infrastructure, from frameworks to analytics platforms.

Apache HTTP Server

Web servers

jQuery

JavaScript libraries

Infomaniak

Hosting

Lightbox

JavaScript libraries

PHP

Programming languages

HSTS

Security

Apple iCloud Mail

Webmail

WordPress

Blogs

Google Maps

Maps

MySQL

Databases

RSS

Miscellaneous

Priority Hints

Performance

Frequently asked questions

Alys Pharmaceuticals is located in US.

Alys Pharmaceuticals was founded in 2024, making it 2 years old. The company has established itself as a significant player in its industry over this time.

Alys Pharmaceuticals has approximately 1-10 employees. The company continues to grow its workforce to support its business operations and expansion.

Alys Pharmaceuticals has raised a total of $100,000,000 across 1 funding rounds. This investment has helped the company grow and expand its operations.

Key Contacts at Alys Pharmaceuticals

Brian S. Kim

Co-Founder

Thibaud Portal

Founder

Mark Prausnitz

Co-Founder

Yann Dean

Co-Founder & Project Lead

Amissi Sadiki

Founder & Head Of Chemistry, Nira Biosciences, Subsidiary Of Alys Pharmaceuticals

4.8